At the 2008 Medical Automation Conference, then Secretary of Technology for the Commonwealth of Virginia, Aneesh Chopra, gave a keynote address [MORE]
The US economy may be contracting sharply in some industries, but drug makers spent $2b more on research in 2008 [MORE]
Several bills now in Congress could result in a fundamental change to patenting biologics (such as monoclonal antibodies). One bill [MORE]
PERSONA, a project of the European Union that promotes independent aging, has been functioning since 2007 and will continue until [MORE]
Thomas Lango, an engineer with SINTEF-a large independent research organization in Norway-have been working with physicians to develop a “smart [MORE]
BioNanoMatrix Technology
No, the $1,000 genome has not yet seen the light of day, but hardly a week goes by without [MORE]
Researchers at the Fraunhofer Institute for Integrated Circuits in Erlangen, Germany had developed a mobile sleep lab for home assessment, [MORE]
Snakebot
Engineering a robotic arm that has snakelike flexibility is no small matter, but that’s what Professor Howie Choset, at Carnegie [MORE]
Abbott’s i-STAT handheld blood analyzer has just received an FDA waiver for five more tests using its 18 cartridges, which [MORE]
Stent
There are currently only four drug-eluting stents under FDA approval, and their effectiveness or ineffectiveness have been called into question. [MORE]
Solianis Monitoring AG (Zurich, Switzerland) has recently completed a study of its wearable, noninvasive, multisensor glucose monitor that tracks blood [MORE]
Genetic Engineering & Biotechnology News reported recently that GSK’s deal with Actelion, worth almost $3.2 billion, for Actelion’s insomnia drug [MORE]
BioWorld Today and Medical Devices Daily has a 200 page market analysis (cost $599) for biomaterials, covering such things as [MORE]